MCID: DRG002
MIFTS: 49

Drug-Induced Hepatitis malady

Summaries for Drug-Induced Hepatitis

About this section
Sources:
63Wikipedia, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Wikipedia:63 Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage. more...

MalaCards: Drug-Induced Hepatitis, also known as hepatitis, chronic, drug-induced, is related to hepatitis and tuberculosis. An important gene associated with Drug-Induced Hepatitis is NAT2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)), and among its related pathways are Acetylation and Arylamine metabolism. The compounds uric acid and benzidine have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and t cells, and related mouse phenotype homeostasis/metabolism.

Aliases & Classifications for Drug-Induced Hepatitis

About this section
Sources:
8Disease Ontology, 60UMLS, 56SNOMED-CT, 34MeSH
See all sources

Aliases & Descriptions:

drug-induced hepatitis 8
hepatitis, chronic, drug-induced 60
drug-induced chronic hepatitis 8
hepatitis, drug-induced 60


External Ids:

Disease Ontology8 DOID:2044
SNOMED-CT56 235889003
MeSH34 D056487

Related Diseases for Drug-Induced Hepatitis

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Drug-Induced Hepatitis via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 144)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis31.5GPT, SLC17A5
2tuberculosis30.7CP, NAT2, CYP2E1
3autoimmune hepatitis30.5UGT1A1, CYP2C9, CYP2D6, GPT, SLC17A5, GSTT1
4pulmonary tuberculosis30.3CP, NAT2, CAT
5psoriasis30.1NAT2
6hyperinsulinism30.0GHR, GLUD1
7melanoma30.0GSTT1, CP, GHR, CAT
8hepatitis a10.7
9hepatic tuberculosis10.5
10granulomatous hepatitis10.2
11renal tuberculosis10.1
12alcoholic hepatitis10.1
13meningitis10.1
14multiple myeloma10.1
15myeloma10.1
16familial adenomatous polyposis10.0NAT2
17lupus erythematosus10.0NAT2
18substance abuse10.0CYP2E1
19esophageal cancer10.0CYP2E1
20malignant mesothelioma10.0NAT2
21alpha thalassemia10.0UGT1A1
22motor neuron disease10.0GSTT1
23ovarian cancer10.0GSTT1
24coronary heart disease10.0GSTT1
25schistosomiasis10.0GSTM1
26crigler-najjar syndrome10.0UGT1A1
27sickle cell disease10.0UGT1A1
28parkinson's disease10.0CYP2D6
29pneumonia10.0GSTM1
30essential hypertension10.0CYP2D6
31primary open angle glaucoma10.0GSTM1
32peptic ulcer10.0CYP2C19
33hemochromatosis10.0CP
34neonatal jaundice10.0UGT1A1, UGT1A6
35atopy10.0GSTT1, NAT2
36diarrhea10.0UGT1A1, UGT1A6
37pancreatic cancer10.0NAT2, NAT1
38leukoplakia10.0GSTM1, GSTT1
39cervical cancer10.0GSTT1, GSTM1
40kernicterus10.0UGT1A1, UGT1A6
41myocardial infarction10.0GSTT1, CYP2C9
42thromboembolism10.0CYP2C9
43deficiency anemia10.0GSTM1, CP
44thyroid cancer10.0GSTT1, GSTM1
45cholecystitis10.0GPT
46sarcoma10.0GSTM1
47asbestosis10.0GSTT1, GSTM1
48diabetic retinopathy10.0SORD
49cleft palate10.0GSTM1, NAT1
50pancreatitis10.0CYP2E1, SLC17A5

Graphical network of the top 20 diseases related to Drug-Induced Hepatitis:



Diseases related to drug-induced hepatitis

Clinical Features for Drug-Induced Hepatitis

About this section

Drugs & Therapeutics for Drug-Induced Hepatitis

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials
See all sources

Approved drugs:

Search CenterWatch for Drug-Induced Hepatitis

Drug clinical trials:

Search ClinicalTrials for Drug-Induced Hepatitis

Search NIH Clinical Center for Drug-Induced Hepatitis

Search CenterWatch for Drug-Induced Hepatitis

Genetic Tests for Drug-Induced Hepatitis

About this section

Anatomical Context for Drug-Induced Hepatitis

About this section
Sources:
30LifeMap Discovery™, 32MalaCards
See all sources

MalaCards organs/tissues related to Drug-Induced Hepatitis:

32
Liver, Testes, T cells

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Drug-Induced Hepatitis:
id TissueAnatomical CompartmentCell Relevance
1 LiverLiver LobuleHepatocytes Affected by disease

Animal Models for Drug-Induced Hepatitis or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Drug-Induced Hepatitis:

36
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053767.5GSTT1, SORD, GHR, GLUD1, CYP2E1, NAT1

Publications for Drug-Induced Hepatitis

About this section
Sources:
50PubMed
See all sources

Articles related to Drug-Induced Hepatitis:

(show top 50)    (show all 111)
idTitleAuthorsYear
1
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. (24274872)
2014
2
A rare coexistence: drug induced hepatitis and meningitis in association with Ibuprofen. (23671551)
2013
3
No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance. (24387833)
2013
4
Efficacy of herbal coded Hepcon on drug induced hepatitis in experimental animals through histopathological and biochemical analysis. (24035958)
2013
5
Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia. (23212742)
2013
6
Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate. (23391366)
2013
7
Anti-tuberculosis drug-induced hepatitis in renal transplant patient with pulmonary and extra pulmonary tuberculosis. (23960791)
2012
8
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma. (22916049)
2012
9
Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism. (22850563)
2012
10
The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis. (22893872)
2012
11
Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. (22885386)
2012
12
Drug induced liver injury and its relationship to autoimmune hepatitis. (21396413)
2011
13
Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. (21855518)
2011
14
Drug-induced autoimmune-like hepatitis: a diagnostic challenge. (21674172)
2011
15
Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis. (21320040)
2011
16
Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal. (21698369)
2011
17
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. (21674554)
2011
18
A Case of Drug-Induced Hepatitis due to Lenalidomide. (21552449)
2011
19
Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. (21338638)
2011
20
NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis. (20392357)
2010
21
Drug-induced hepatitis and lupus during infliximab treatment for psoriasis: case report and literature review. (20338127)
2010
22
Zhixue capsule caused seven cases of drug induced hepatitis. (20698229)
2010
23
Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor I+ agents. (20715094)
2010
24
The effect of GST M1 and GST T1 gene mutations on anti-tuberculous drug induced hepatic injury]. (19576039)
2009
25
Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. (19891553)
2009
26
Drug-induced hepatitis superimposed on the presence of anti-SLA antibody: a case report. (18226219)
2008
27
Drug induced hepatitis with anti-tubercular chemotherapy: challenges and difficulties in treatment. (18604033)
2007
28
Drug-induced hepatitis - morphological and ultrastructural aspects. (18060200)
2007
29
Acute drug induced hepatitis secondary to a weight loss product purchased over the internet. (17597525)
2007
30
Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy. (16645237)
2006
31
Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis. (16467335)
2006
32
Drug-induced hepatitis with saquinavir/ritonavir + rifampin. (15828118)
2005
33
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]. (15599214)
2005
34
Clinical evaluation of drug-induced hepatitis. (15982181)
2005
35
Drug-induced hepatitis due to repeated use of hair dye. (14686750)
2003
36
Dramatic increase in bilirubin after ERCP - pethidine as a possible cause of drug-induced hepatitis. (14661125)
2003
37
Drug-induced hepatitis with hepatic granuloma due to saridon. (12522541)
2002
38
Comment: history of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. (11793648)
2001
39
Effects of the enterosorbent SUMS-1 on isoniazid pharmacokinetics and lipid peroxidation in patients with pulmonary tuberculosis and drug-induced hepatic lesions]. (11508231)
2001
40
Diagnostic value of T cell reactivity in drug induced hepatitis. (9917196)
1998
41
Immunoallergic drug-induced hepatitis: lessons from halothane. (9138123)
1997
42
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. (9138125)
1997
43
Drug-specific T cells derived from patients with drug-induced allergic hepatitis. (1378078)
1992
44
Drug induced hepatitis. (1784106)
1991
45
Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis? (1904700)
1991
46
Drug-induced and toxic granulomatous hepatitis. (3044471)
1988
47
Acute and chronic drug-induced hepatitis. (3044468)
1988
48
Drug-induced hepatitis and lymphocyte transformation test in presence of prostaglandin inhibitor. (2871443)
1986
49
Drug-induced granulomatous hepatitis. (7453131)
1981
50
Recognition, prevention, and treatment of drug-induced hepatitis. (5766633)
1969

Genetic Variations for Drug-Induced Hepatitis

About this section

Expression for genes affiliated with Drug-Induced Hepatitis

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Drug-Induced Hepatitis

Search GEO for disease gene expression data for Drug-Induced Hepatitis.

Pathways for genes affiliated with Drug-Induced Hepatitis

About this section
Sources:
53Reactome, 37NCBI BioSystems Database, 49PharmGKB, 29KEGG, 12EMD Millipore
See all sources

Pathways related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 32)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
110.1NAT2, NAT1
210.1NAT2, NAT1
310.1GSTM1, GSTT1
410.1GSTT1, GSTM1
5
Hide members
10.0CYP2D6, UGT1A1
6
Hide members
10.0CYP2E1, CAT
7
Hide members
9.9UGT1A3, UGT1A1, UGT1A6
89.9NAT1, NAT2, GSTM1
99.8UGT1A6, UGT1A3, CYP2C9
10
Hide members
9.8CYP2C9, CYP2E1, CYP2C19
119.8CYP2C19, CYP2E1, CYP2C9
12
Hide members
9.7CYP2C19, CYP2C9, UGT1A6
13
Hide members
9.7UGT1A6, UGT1A1, UGT1A3, GSTM1
14
Hide members
9.7CYP2C19, CYP2D6, CYP2C9
15
Hide members
9.7CYP2C19, CYP2D6, CYP2C9
16
Hide members
9.6CYP2C9, CYP2E1, NAT1, NAT2
17
Naphthalene metabolism
Hide members
9.6CYP2C9, CYP2E1, GSTM1, GSTT1
189.6CYP2C19, CYP2C9, GHR
19
Hide members
9.5UGT1A6, UGT1A1, UGT1A3, NAT1, NAT2
20
Hide members
9.5CYP2C9, CYP2D6, CYP2E1, CYP2C19
21
Hide members
9.5CYP2C9, CYP2D6, CYP2E1, CYP2C19
22
Hide members
9.5UGT1A1, CYP2C9, CYP2D6, CYP2C19
23
Hide members
9.5UGT1A1, CYP2C9, CYP2D6, CYP2C19
24
Retinol metabolism
Hide members
9.3UGT1A3, CYP2C9, CYP2D6, CYP2E1, CYP2C19
25
Acetaminophen metabolism
Hide members
9.3UGT1A6, UGT1A1, UGT1A3, CYP2D6, CYP2E1, NAT2
26
Hide members
9.3UGT1A1, UGT1A3, CYP2C9, CYP2D6, CYP2C19
27
Hide members
9.1UGT1A6, UGT1A1, CYP2C9, CYP2D6, CYP2E1, CYP2C19
28
Hide members
9.0UGT1A1, UGT1A3, CYP2C9, CYP2D6, CYP2E1, CYP2C19
29
Hide members
8.9NAT1, NAT2, B3GAT2, GPT, GSTM1, GSTT1
30
Hide members
8.1GSTT1, UGT1A6, GSTM1, NAT2, NAT1, CYP2C19
31
Hide members
8.1NAT2, NAT1, CYP2C19, CYP2E1, CYP2D6, CYP2C9
32
Hide members
7.9CAT, SORD, UGT1A6, UGT1A1, UGT1A3, GLUD1

Compounds for genes affiliated with Drug-Induced Hepatitis

About this section
Sources:
44Novoseek, 24HMDB, 11DrugBank, 49PharmGKB, 28IUPHAR, 2BitterDB, 59Tocris Bioscience
See all sources

Compounds related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show top 50)    (show all 421)
idCompoundScoreTop Affiliating Genes
1uric acid44 2410.9GHR, GLUD1
2benzidine449.8UGT1A6, NAT2, GSTM1, GSTT1, UGT1A1
3trichloroethylene449.8NAT2, CYP2E1, GSTT1, GSTM1, GPT
4Sulfanilamide119.8CYP2C9, CYP2D6, CYP2C19, CYP2E1
5mephenytoin44 49 1111.7CYP2D6, CYP2E1, CYP2C19, NAT2, CYP2C9
6flunitrazepam44 28 1111.7CYP2E1, CYP2C9, UGT1A3, UGT1A1, CYP2C19
7gsts449.6CYP2E1, NAT1, CYP2D6, GSTM1, GSTT1, NAT2
8Trabectedin119.6CYP2C19, CYP2D6, CYP2C9, CYP2E1
9p-nitrophenol44 1110.6UGT1A6, UGT1A3, CYP2C9, UGT1A1, CYP2D6, CYP2E1
10arylamine449.6GSTM1, CYP2D6, CYP2C19, NAT1, NAT2, GSTT1
11thiopurine449.6UGT1A1, CYP2C19, CYP2D6, CYP2C9, NAT2
12debrisoquine449.6CYP2E1, CYP2D6, GSTM1, CYP2C9, CYP2C19, NAT2
13rifampin49 1110.6UGT1A1, CYP2C9, CYP2E1, CYP2C19, NAT1, NAT2
14cotinine44 2410.5UGT1A3, CYP2D6, NAT2, GSTM1, GSTT1, UGT1A1
15benzo(a)pyrene449.5GSTM1, UGT1A1, CYP2C9, UGT1A6, NAT2, GSTT1
16paraxanthine44 2410.5NAT2, NAT1, CYP2D6, CYP2E1, CYP2C19, CYP2C9
17dapsone2 44 49 1112.5NAT1, CYP2C19, CYP2E1, CYP2D6, CYP2C9, NAT2
18vitamin a44 11 2411.5NAT2, CAT, CYP2E1, CP, GHR
19beta-naphthoflavone44 1110.5CYP2D6, UGT1A6, UGT1A1, CYP2E1, CYP2C19, CYP2C9
20tolbutamide44 49 28 1112.5CYP2D6, CYP2C9, CYP2E1, CYP2C19, NAT2, GLUD1
21chlorzoxazone44 28 1111.4NAT2, CYP2C9, CYP2D6, CYP2E1, SLC17A5, CYP2C19
22antipyrine44 1110.4SLC17A5, CYP2D6, CYP2E1, CYP2C19, CYP2C9
23buprenorphine44 28 1111.4SLC17A5, UGT1A3, CYP2C19, CYP2D6, CYP2C9, UGT1A1
24propofol44 49 1111.4CYP2C19, CYP2E1, CYP2D6, CYP2C9, UGT1A3, UGT1A1
25aflatoxin b144 2410.4GSTT1, NAT1, GSTM1, NAT2, SLC17A5
26codeine44 49 28 11 2413.4CYP2E1, CYP2D6, UGT1A6, UGT1A1, CYP2C19, UGT1A3
27diclofenac44 28 49 1112.4CYP2C19, CYP2E1, CYP2C9, UGT1A6, UGT1A3, CYP2D6
28imipramine44 49 28 11 2413.3CYP2D6, UGT1A6, UGT1A1, UGT1A3, CYP2C9, CYP2E1
29estrone44 28 11 2412.3CYP2C19, UGT1A6, CYP2E1, CYP2D6, CYP2C9, UGT1A3
30fluvastatin44 49 28 1112.2CYP2C9, UGT1A1, GPT, CYP2D6, UGT1A3, CYP2C19
31uridine diphosphate449.2UGT1A3, UGT1A1, UGT1A6, CYP2C9, NAT2, CYP2C19
32phenytoin44 49 28 1112.2UGT1A1, CYP2C9, CYP2D6, CYP2C19, SLC17A5, CP
33betacarotene449.2GSTM1, CP, SLC17A5, NAT2, CYP2E1, CAT
34hydrocarbons449.1GSTM1, NAT2, CYP2C9, UGT1A1, GSTT1
35selegiline44 1110.1CYP2E1, CYP2C19, CAT, CYP2C9, CYP2D6
36oxygen44 2410.1GHR, CYP2D6, CYP2C19, GSTM1, BCL2L15, CYP2C9
37troglitazone44 28 59 1112.0UGT1A3, GPT, UGT1A1, UGT1A6, CYP2C9, SLC17A5
38acetaminophen44 2 49 11 2413.0GPT, NAT2, CYP2C19, CYP2E1, CYP2C9, UGT1A6
39atorvastatin44 49 28 11 2413.0UGT1A1, UGT1A3, CYP2C9, CYP2D6, CYP2C19, GPT
40tamoxifen44 49 28 1112.0CYP2C9, UGT1A3, UGT1A1, CYP2D6, CYP2E1, UGT1A6
41malondialdehyde449.0GSTT1, SLC17A5, CP, GSTM1, CAT, GPT
42epoxide449.0GSTT1, GSTM1, NAT2, NAT1, CYP2C19, CYP2E1
43phenobarbital44 28 1110.9SLC17A5, GSTM1, CP, CYP2C19, CYP2E1, CYP2C9
44simvastatin44 49 59 28 11 2413.9CYP2C19, SLC17A5, CYP2D6, CYP2C9, UGT1A3, UGT1A1
45rifampicin44 28 5910.8UGT1A6, CYP2C9, CYP2D6, CYP2E1, CYP2C19, SLC17A5
46nicotine44 49 28 1111.7UGT1A6, CYP2C9, CYP2D6, CYP2E1, CYP2C19, GPT
47valproic acid44 49 11 2411.5CYP2C19, GPT, SLC17A5, CYP2E1, CYP2D6, CP
48isoniazid49 44 1110.2GPT, SLC17A5, GSTM1, GSTT1, NAT2, CAT
49creatinine448.0GHR, GLUD1, CYP2E1, SLC17A5, CP, GSTM1
50testosterone44 59 11 2410.8CYP2E1, CYP2C19, SLC17A5, CP, GSTM1, CYP2C9

GO Terms for genes affiliated with Drug-Induced Hepatitis

About this section
Sources:
16Gene Ontology
See all sources

Cellular components related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum membraneGO:0057898.9CYP2C19, CYP2E1, CYP2D6, CYP2C9, UGT1A3, UGT1A1

Biological processes related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1xenobiotic glucuronidationGO:05269710.3UGT1A1, UGT1A3
2flavonoid glucuronidationGO:05269610.2UGT1A1, UGT1A3
3cellular glucuronidationGO:05269510.1UGT1A1, UGT1A6
4drug catabolic processGO:04273710.1CYP2C9, CYP2D6
5omega-hydroxylase P450 pathwayGO:09726710.0CYP2C9, CYP2C19
6oxidative demethylationGO:07098910.0CYP2C9, CYP2D6
7heterocycle metabolic processGO:0464839.8UGT1A1, CYP2D6, CYP2E1, CYP2C19
8exogenous drug catabolic processGO:0427389.8CYP2C19, CYP2C9
9monoterpenoid metabolic processGO:0160989.8CYP2C9, CYP2D6, CYP2E1, CYP2C19
10oxidation-reduction processGO:0551149.7CYP2C9, CYP2D6, CYP2E1, CYP2C19
11epoxygenase P450 pathwayGO:0193739.6CYP2C19, CYP2C9
12drug metabolic processGO:0171449.5UGT1A1, CYP2C9, CYP2D6, CYP2E1, CYP2C19
13steroid metabolic processGO:0082029.5CYP2C19, CYP2E1, CYP2D6, CYP2C9, UGT1A1
14xenobiotic metabolic processGO:0068058.6GSTT1, UGT1A6, UGT1A1, CYP2C9, CYP2D6, CYP2E1
15small molecule metabolic processGO:0442817.2CYP2D6, CYP2C9, GLUD1, UGT1A1, UGT1A6, CAT

Molecular functions related to Drug-Induced Hepatitis according to GeneCards/GeneDecks:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1arylamine N-acetyltransferase activityGO:00406010.2NAT1, NAT2
2retinoic acid bindingGO:00197210.1UGT1A3, UGT1A1, UGT1A6
3glucuronosyltransferase activityGO:01502010.1UGT1A6, UGT1A1, UGT1A3
4(R)-limonene 6-monooxygenase activityGO:05274110.1CYP2C9, CYP2C19
5(S)-limonene 7-monooxygenase activityGO:01867610.1CYP2C9, CYP2C19
6(S)-limonene 6-monooxygenase activityGO:01867510.0CYP2C9, CYP2C19
7steroid hydroxylase activityGO:0083959.9CYP2C19, CYP2C9
8monooxygenase activityGO:0044979.8CYP2C19, CYP2E1, CYP2D6, CYP2C9
9oxidoreductase activityGO:0164919.8CYP2C9, CYP2D6, CYP2E1, CYP2C19
10heme bindingGO:0200379.4CAT, CYP2C9, CYP2D6, CYP2E1, CYP2C19
11iron ion bindingGO:0055069.4CYP2C9, CYP2D6, CYP2E1, CYP2C19
12electron carrier activityGO:0090559.2CYP2C19, CYP2E1, CYP2D6, CYP2C9
13enzyme bindingGO:0198999.2GSTM1, CAT, UGT1A6, UGT1A1, UGT1A3, CYP2E1
14protein homodimerization activityGO:0428039.0CAT, UGT1A6, UGT1A1, UGT1A3, GHR, GSTM1

Products for genes affiliated with Drug-Induced Hepatitis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Drug-Induced Hepatitis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet